Upload
mayur-wagh
View
80
Download
0
Embed Size (px)
Citation preview
A SEMINAR ON LIPOSOME DRUG DELIVERY FOR
OPHTHALMICS
PRESENTED BY-Mr. Mayur R. WaghM.Pharm 1ST Sem
(PHARMACEUTICS)
GUIDED BY-Dr. (Mrs.) Pallavi
Chaudhari
Dr. D.Y. Patil College of Pharmacy, Akurdi, Pune-44
09/11/2016
2
CONTENTS-• DEFINATION OF LIPOSOMES• CLASSIFICATION OF LIPOSOMES• ADVANTAGES & DISADVANTAGES OF
LIPOSOMES• OCULAR DRUG DELIVERY SYSTEM• VESICULAR OCULAR DRUG DELIVERY SYSTEM
OF LIPOSOMES• APPLICATIONS OF LIPOSOMES• REFRENCES
3
INTRODUCTION OF LIPOSOMES:- Liposomes are concentric bilayered vesicles in which an aqueous volume is entirely enclosed by a membranous lipid bilayer mainly composed of natural or synthetic phospholipids
Liposomes were discovered about 40 years ago by Alec Bangham
4
• Liposomes can be produced from cholesterols, non toxic surfactants, sphingolipids, glycolipids, long chain fatty acids & even membrane proteins
• Liposomes are the drug carrier loaded with great variety of molecules such as small drug molecules, proteins, nucleotides & even plasmids
• Considerable progress was made during 1970s and 1980s in the field of liposome stability leading to long circulation times of liposomes
INTRODUCTION-
5
STRUCTURAL COMPONENTS :
6
CLASSIFICATION:VESICLE TYPE ABBREVIATI
ONDIAMETER SIZE
NO. OF LIPID BI - LAYER
Unilamellar vesicle UV All size range ONE
Small unilamellar vesicle SUV 20-100 nm ONE
Medium unilamellar vesicle
MUV >100 nm ONE
Large unilamellar vesicle LUV >1000 nm ONE
Giant unilamellar vesicle
GUV >1µm ONE
Oligolamellar vesicle OLV 0.1-1µm 5
Multilamellar vesicle MLV >0.5µm 5-25
Multivesicular vesicle MV >1µm Multicompartmental structure
7
ADVANTAGES Drugs delivered intact to various
body tissues.
Liposomes can be used for both
hydrophilic and hydrophobic drug.
Possibility of targeting and
decrease drug toxicity.
The size, charge and other
characteristics can be altered
according to drug and desired
tissue.
DISADVANTAGESThey need many modification
for drug delivery to special
organs.
Stability problem and
oxidative degradation.
Requires special packaging
and storing facility.
Costly.
8
Liposomes in drug delivery:• Liposomes are microparticulate lipoidal vesicles
which are under extensive investigation as drug carriers for improving the delivery of therapeutic agents
• Composed of relatively biocompatible and biodegradable material, and they consist of an aqueous volume entrapped by one or more bilayers of natural and/or synthetic lipids
• Drugs with widely varying lipophilicities can be encapsulated in liposomes, either in the Phospholipid bilayer or at the bilayer interface
9
Ideal Characteristics of Liposomes-
• It should be non-toxic, biocompatible, biodegradable
• Therapeutic amount of drug release
• Physicochemical stable in-vivo and in-vitro
• Drug release does not affect the drug action
10
OCULAR DRUG DELIVERY SYSTEM –
• Ocular administration of drug is associated with the need to treat ophthalmic diseases
• Eye is most easily accessible site for topical administration of medication
• Ideal ophthalmic drug delivery system is the one which is able to sustain the drug release and to remain in the vicinity of front of the eye for prolonged period of time
• Most ocular treatments call for the topical
administration of opthalmically active drugs to tissue around the ocular activity
11
Anatomy of the Eye-
12
ROUTES OF DRUG DELIVERY IN EYE-
13
Absorption barriers for topical drug delivery-
1. Corneal Barrier
2. Tear Film Barrier
3. Scleral Barrier
4. Conjunctival Barrier
14
Mechanisms of permeation of liposomes throughocular surface-
• The mechanisms of interaction of liposomes with cell membranes that result into intracellular drug delivery
• Four mechanisms of intracellular drug delivery by liposomes -:
1. Adsorption: Adsorption of liposomes to cell membrane is one of the important mechanisms of intracellular drug delivery
2. Endocytosis: Adsorption of liposomes on the surface of cell membrane is followed by their engulfment and internalization into endosomes
15
3. Fusion: Fusion of lipid bilayer of liposomes with lipoidal cell membrane by intermixing and lateral diffusion of lipids results in direct delivery of liposomal contents into the cytoplasm
4. Lipid exchange: Due to the similarity of liposomal membrane lipids with the cell membrane phospholipids, lipid transfer proteins in the cell membrane recognize liposomes and consequently cause lipid exchange.
• This results in the destabilization of liposomal membranes and intracellular release of drug molecules
Mechanisms of intracellular drug delivery by liposomes -:
16
Routes of drug Administration-
• Topical Administration-• Drops• Perfusion• Sprays•Ointments• Particulates
• Intraocular drug delivery-• Liposomes•Microparticulates and nanoparticles• Intraocular devices• Iontophoresis
17
FACTORS AFFECTING INTRAOCULAR BIOAVAILABILITY :-
1. Inflow & Outflow of Lacrimal fluids2. Efficient naso-lacrimal drainage3. Interaction of drug with proteins of Lacrimal fluid4. Dilution with tears5. Limited and poor corneal permeability 6. Metabolism
18
VESICULAR OCULAR DRUG DELIVERY SYSTEM – LIPOSOMES
• Deliver the drug at a predetermined rate and should release the drug at the specific site of action in therapeutically active concentration
• Drug delivery via vesicles provides prolonged as well as controlled drug delivery at the targeted corneal surface
• Thus, a vesicle acts as prominent carrier system for ophthalmic drug delivery
• Vesicular drug delivery systems entrap the drug molecule within the lipid bilayer or surfactant vesicles
19
• At the corneal surface of an eye also prevent the metabolism of the drug by the enzymes that are present at the tear/corneal epithelial surface
• Vesicles used in ophthalmic include liposome and niosomes specifically
• Liposome act as carrier system for the delivery of variety of drug molecules, proteins, nucleotides, enclosing them with a great potential for their application in ophthalmic
VESICULAR OCULAR DRUG DELIVERY SYSTEM – LIPOSOMES
They are having an intimate contact with the corneal and conjunctival surfaces
Which is desirable for drugs that are poorly absorbed, the drugs with low partition coefficient, poor solubility or those with medium to high molecular weights
20
21
• Liposomal encapsulation has the drug in the eye, but also to reduce the intraocular toxicity of certain drugs
• For example, liposome-encapsulated amphotericin B produces less toxicity than the commercial solubilized amphotericin B formulation when injected intravitreally
• Vesicle composed of phospholipid bilayer enclosing aqueous compartment in alternate fashion
• It is Biodegradable, Non-toxic in nature
VESICULAR OCULAR DRUG DELIVERY SYSTEM – LIPOSOMES-
22
• Applications of Liposomes In Ophthalmic Drug Delivery-:
• Subconjunctival injection of liposomes can provide retentive effect and steady-state release at the site of application E.g. Heparin
• It can enhance the permeation of poorly absorbed drug molecules by binding to the corneal surface and improving residence time E.g. Ciprofloxacin
• liposomes can improve pharmacokinetic profile, enhance therapeutic effect, and reduce toxicity associated with higher dose E.g. fluconazole
• liposomes have been widely investigated for the treatment of both anterior and posterior segment eye disorders.
23
PATENTS IN LIPOSOMAL DRUG DELIVERY(OCULAR)
TITLE AUTHOR NAME
PATENT NO.
PUBLICATION DATE
Liposome System For Ocular Administration
Subramanian Venkatraman, Sujay
Chattopaddhay. WO
2011098578A2
16 Feb. 2012
A Liposomal Formulation For Ocular Drug Delivery
Yian Chiang Freddy Boey, Tina Wong.
WO 20120211
07 A3
29 Nov. 2012
Liposomal Formulation For Ocular Drug Delivery
Jayaganesh V. Natranjan,
Subramanian Venkatraman
US 20130216
606A122 Aug.
2013
24